Abstract:[Objective] To evaluate the value of application on BALB/c mice bearing liver cancer H22 imaging with hypoxia-avid agent ~(99)Tc~m HL91.[Methods] One mg HL91 was dissolved in 2 mL sterile sodium pertechnetate solution containing 1110 MBq(30mCi) ~(99)Tc~m.A stannous DTPA kit was reconstituted with 10 mL saline,an aliquot of 50 μL was removed and added to the vial containing HL91 and pertechnetate.After 10 minutes at room temperature,the radiochemical purity of the preparation of ~(99)Tc~m-HL91 was determined before use by paper and thin-layer chromatography,and exceeded 95%.There are 13 BALB/c mice bearing liver cancer HCa-F in the research.After anaesthesia,HL91(37 MBq) was injected intravenously.Three mice were underwent whole body planar static imaging after 2 h injection of ~(99)Tc~m-HL91,and five mice after 4 h,other five mice after 6h were also performed the same whole body planar imaging.Four regions of interest(ROI) were set on the tumor,head,abdomen and the thorax opposing to the thorax near tumor in the imaging.The radioactivity in the ROIs was measured.The tumor-to-normal tissue ratios of tumor to head,abdomen and thorax were calculated.[Results] All of the tumor were found ~(99)Tc~m-HL91 uptake.The uptake of HL91 in the tumor reached a peak at 4 h and then gradually decreased.After 6h postinjection of ~(99)Tc~m-HL91,the radioactivity of tumor was descended slightly.HL91 accumulated to highly levels in the hypoxic area than in other tissues except for abdomen.The tumor-to-normal tissue ratios of tumor to head,thorax and abdomen were 4.26±2.29,3.40±0.91,0.41±0.19,respectively.The ratio of T/NT at 4 h or 6 h is higher than that of 2 h,there were significant difference(P0.01).The T/NT continued increase until 6 h postinjection of ~(99)Tc~m-HL91.However,The radioactivity of abdomen was higher than tumor.[Conclusions] High uptake of ~(99)Tc~m-HL91 in the tumor of BALB/c mice bearing liver cancer H22(H-2),and the clearance rate is slower.High T/NT can be obtained after 4 h injection of ~(99)Tc~m-HL91.T/NT is a very important index in tumor hypoxic imaging.

Somatostatin receptor subtype 2-mediated scintigraphy and localization using 99mTc-HYNIC-Tyr3-octreotide in human hepatocellular carcinoma-bearing nude mice

(99M)tc-Labeled Dimeric Octreotide Peptide: a Radiotracer with High Tumor Uptake for Single-Photon Emission Computed Tomography Imaging of Somatostatin Receptor Subtype 2-Positive Tumors.

Anti-carcinoma Effect of Targeted Radiotherapy Using 90Y-Dota-octreotide Mediated by Somatostatin Receptor

[Preliminary Clinical Application of 99Tcm-Hynic-toc Imaging in Somatostatin Receptor-Positive Tumors].

Imaging and Therapy of Hsstr2-Transfected Tumors Using Radiolabeled Somatostatin Analogs

Sodium Pump Na Plus /K Plus ATPase Subunit 1-Targeted Positron Emission Tomography Imaging of Hepatocellular Carcinoma in Mouse Models

Animal SPECT/CT imaging and radiation dosimetry of~(99m)Tc-HYNIC-TOC

Somatostatin Receptor Based Imaging and Radionuclide Therapy

SSTR2-targeted theranostics in hepatocellular carcinoma

Preparation and Evaluation of Tc-99m-Labeled Dimeric Tyr(3)-Octreotide in the Ar42j Tumor Model

Evaluation of 99Mtc-Hydrazinonicotinamide-tyr3-octreotide SPECT/CT in Detection of Liver Metastases in Patients with Neuroendocrine Tumors

Small-Animal Spect/Ct Imaging with 99Mtc-Hynic-h10f Detects Her2 Expression in Mice Bearing Human Breast Cancers

[Expression of Somatostatin Receptor Reporter Gene and Its Correlation with Targeted Imaging in Vivo for Detection of Pancreas Carcinoma].

An Experimental Study on Mice Bearing Liver Cancer Imaging with ~(99)Tc~m-Hl91

[Use of 99Mtc-Survivin Antisense Oligonucleotide in Diagnosis of Hepatocellular Carcinoma: an Experiment with Mice].

Investigation of SP94 Peptide As a Specific Probe for Hepatocellular Carcinoma Imaging and Therapy

Radio-synthesis, Quality Control and Micro-PET Imaging of Cu-64-DOTA-TATE

Design and Preliminary Assessment of 99m Tc-labeled Ultrasmall Superparamagnetic Iron Oxide-Conjugated Bevacizumab for Single Photon Emission Computed Tomography/magnetic Resonance Imaging of Hepatocellular Carcinoma

The Imaging of ~(99)Tc~m-Hynic-toc in Pancreatic Tumor Borne Nude Mice

Treatment of Hepatocellular Carcinoma by Intratumoral Injection of 125I-AA98 Mab and Its Efficacy Assessments by Molecular Imaging.

Radioimmunoimaging of human hepatocellular carcinoma xenografts with 131I-anti-HBx monoclonal antibody